British sporting legend Colin Jackson was at the London Hippodrome today to launch his new charity project for men – The Sanlam Go Dad Run. The Sanlam Go Dad Runs are a series of 5K runs, for men and boys aged 14 and over, that will take place in Cardiff, London and Birmingham on Father’s Day weekend June 14 and 15 to raise funds for and awareness of Prostate Cancer UK.

Read more

Today 19 March 2014, the National Institute for Health and Care Excellence (NICE) is holding its final committee meeting to appraise advanced prostate cancer drug enzalutamide for use on the NHS in England and Wales for men who have already had chemotherapy. Since January Prostate Cancer UK has been spearheading a campaign against proposed restrictions in access to the life-extending treatment which have sparked outrage among thousands affected by the disease across the country.

Read more

In October we reported the good news that the National Institute for Health and Care Excellence (NICE) had provisionally approved enzalutamide, a life-extending cancer drug, for men with advanced prostate cancer who have stopped responding to hormone therapy and chemotherapy. However, today NICE has revised that draft decision, and says that enzalutamide should only be made available post chemotherapy to those men who haven’t already been treated with abiraterone – the only other available treatment for men at this stage of the disease.

Read more